Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.1900+0.0800 (+3.79%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
14,238
14,238
9,975
10,217
8,561
Cost of revenue
5,833
5,833
5,244
4,584
3,648
Gross profit
8,405
8,405
4,731
5,633
4,913
Operating expenses
Research development
873
873
1,255
1,498
2,759
Selling general and administrative
8,911
8,911
7,593
7,195
6,466
Total operating expenses
9,998
9,998
9,066
8,885
9,417
Operating income or loss
-1,593
-1,593
-4,335
-3,252
-4,504
Interest expense
2
2
20
41
110
Total other income/expenses net
-44
-44
64
499
77
Income before tax
-1,575
-1,575
-4,277
-2,784
-4,526
Income tax expense
-
-
-
-
0
Income from continuing operations
-1,575
-1,575
-4,277
-2,784
-4,526
Net income
-1,575
-1,575
-7,382
-4,107
-4,766
Net income available to common shareholders
-1,575
-1,575
-7,382
-4,107
-4,766
Basic EPS
-0.21
-0.15
-0.70
-0.41
-0.52
Diluted EPS
-0.21
-0.15
-0.70
-0.41
-0.52
Basic average shares
10,353
10,386
10,297
10,018
9,079
Diluted average shares
10,353
10,386
10,297
10,018
9,079